Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

March 28, 2015 10:00 PM ET

Life Sciences Tools and Services

Company Overview of Complete Genomics, Inc.

Executive Profile

Douglas A. Lauffenburger Ph.D.

Member of Scientific Advisory Board, Merrimack Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 7 different industries.

See Board Relationships


Dr. Douglas A. Lauffenburger, Ph. D. (Doug) serves as Director of Biological Engineering Division of Massachusetts Institute of Technology (MIT) and its Co-Director of Bioengineering & Environmental Health. Dr. Lauffenburger serves as Consultant of Astra-Zeneca, CellPro, Entelos, Inc., Insert Therapeutics, Inc., Johnson & Johnson, Pfizer, SyStemix, the Burroughs-Wellcome Foundation and the Whitaker Foundation. He is Uncas & Helen Whitaker Professor of Bioengineering, ...

Corporate Headquarters

2071 Stierlin Court
Mountain View, California 94043

United States

Phone: 650-943-2800
Fax: --

Board Members Memberships

Member of the Scientific Advisory Board


University of Minnesota
BS 1975
University of Illinois-Urbana-Champaign

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Complete Genomics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at